BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11056496)

  • 21. [Primary culture of benign prostatic hyperplasia stromal cell].
    Liu LR; Liu ZH; Wei Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 May; 41(3):518-22. PubMed ID: 20629336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Molecular and endocrinological mechanism of benign prostatic hyperplasia and prostate cancer].
    Kinoshita H; Habuchi T; Ogawa O
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():23-7. PubMed ID: 12599539
    [No Abstract]   [Full Text] [Related]  

  • 23. Stromal nodules in benign prostatic hyperplasia.
    Bierhoff E; Vogel J; Benz M; Giefer T; Wernert N; Pfeifer U
    Eur Urol; 1996; 29(3):345-54. PubMed ID: 8740022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Atypical stromal hyperplasia of the prostate (stromal proliferation of uncertain malignant potential)].
    Medina Pérez M; Valero Puerta JA; Pérez Martín D
    Arch Esp Urol; 2000 Oct; 53(8):722-3. PubMed ID: 11126975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary prostate stromal cells modulate the morphology and migration of primary prostate epithelial cells in type 1 collagen gels.
    Hall JA; Maitland NJ; Stower M; Lang SH
    Cancer Res; 2002 Jan; 62(1):58-62. PubMed ID: 11782359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction and function of CYR61 (CCN1) in prostatic stromal and epithelial cells: CYR61 is required for prostatic cell proliferation.
    Kaplan SA
    J Urol; 2005 Sep; 174(3):1012. PubMed ID: 16094032
    [No Abstract]   [Full Text] [Related]  

  • 27. Age-related changes of histological composition in established benign prostatic hyperplasia.
    Ishigooka M; Hayami S; Suzuki Y; Hashimoto T; Sasagawa I; Nakada T
    Eur Urol; 1996; 29(1):85-9. PubMed ID: 8821697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-18 may lead to benign prostatic hyperplasia via thrombospondin-1 production in prostatic smooth muscle cells.
    Hamakawa T; Sasaki S; Shibata Y; Imura M; Kubota Y; Kojima Y; Kohri K
    Prostate; 2014 May; 74(6):590-601. PubMed ID: 24615654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A historical perspective on the role of stroma in the pathogenesis of benign prostatic hyperplasia.
    Cunha GR; Ricke WA
    Differentiation; 2011; 82(4-5):168-72. PubMed ID: 21723032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Androgen and prostatic stroma.
    Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
    Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anatomy of the prostate: insight into benign prostatic hyperplasia anatomy and pathogenesis.
    Villers A
    Prog Clin Biol Res; 1994; 386():21-30. PubMed ID: 7528390
    [No Abstract]   [Full Text] [Related]  

  • 32. Primary culture of smooth muscle cells from benign prostatic hyperplasia.
    Wu YX; Kawabe K
    J Smooth Muscle Res; 1994 Apr; 30(2):51-6. PubMed ID: 7519907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of percent area density of epithelial and stromal components in development of prostatic hyperplasia in spontaneously hypertensive rats.
    Yamashita M; Zhang X; Shiraishi T; Uetsuki H; Kakehi Y
    Urology; 2003 Feb; 61(2):484-9. PubMed ID: 12597986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of proliferation and differentiation of prostatic stromal cells by oestradiol through prostatic epithelial cells in a paracrine manner.
    Wu Q; Shi J; Chen L; Wang CY; Park I; Lee C; Zhang J
    BJU Int; 2008 Feb; 101(4):497-502. PubMed ID: 18190643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rho kinase activation mediates adrenergic and cholinergic smooth muscle contractile responses in the mouse prostate gland.
    White CW; Short JL; Ventura S
    Eur J Pharmacol; 2013 Dec; 721(1-3):313-21. PubMed ID: 24055190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogens and prostatic disease. International Prostate Health Council Study Group.
    Griffiths K
    Prostate; 2000 Oct; 45(2):87-100. PubMed ID: 11027407
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of alpha(1)-adrenoceptor (alpha(1)-AR) antagonists on cell proliferation and apoptosis in the prostate: therapeutic implications in prostatic disease.
    Kyprianou N; Chon J; Benning CM
    Prostate Suppl; 2000; 9():42-6. PubMed ID: 11056502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia.
    Giri D; Ittmann M
    Am J Pathol; 2001 Jul; 159(1):139-47. PubMed ID: 11438462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stromal/epithelial interactions of murine prostatic cell lines in vivo: a model for benign prostatic hyperplasia and the effect of doxazosin on tissue size.
    Takao T; Tsujimura A; Coetzee S; Salm SN; Lepor H; Shapiro E; Moscatelli D; Wilson EL
    Prostate; 2003 Jan; 54(1):17-24. PubMed ID: 12481251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Epithelial and stromal cell relation in peritumorous zone of the prostate gland cancer].
    Fedoseenko KV; Pecherskiĭ AV; Karpishchenko AI
    Tsitologiia; 2004; 46(8):710-3. PubMed ID: 15598017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.